Poster Abstract Session:
139. Clinical Infectious Diseases: Respiratory Infections
Friday, October 28, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Pediatric ID, Investigative ID, Adult ID

Presentations:
A Randomized Comparison of Minocycline and Tosufloxacin for the Treatment of clinically Macrolide-resistant Mycoplasma pneumoniae Pneumonia in ≥ 8 years old Japanese Children
Kensei Gotoh, MD ; Naoko Nishimura, MD ; Syuta Kito, MD ; Kazunori Haruta, MD ; Kei Kozawa, MD ; Hiromi Hibino, MD ; Masahiro Kawaguchi, MD ; Tomoyasu Noguchi, MD ; Naozumi Fujishiro, MD ; Koji Takemoto, MD ; Takao Ozaki, MD
Tigecycline (TG) Salvage Therapy for Legionnaires’ disease (LD) in Severely Ill Patients
Deepika Slawek, MD, MPH ; Diana Altshuler, PharmD ; Yanina Dubrovskaya, PharmD ; Eddie Louie, MD
Posters
  • TGLD1222.pdf (227.8 kB)
  • Bordetella pertussis infection in infants hospitalized for acute bronchiolitis
    Zafer Kurugol Sr., Professor ; Sule Gokce, pediatrist ; Sohret Aydemir, Professor ; Asli Aslan, pediatrist ; Guldane Koturoglu, professor
    Posters
  • Slayt1.GIF (264.9 kB)
  • Epidemiological and Clinical data of Bordetella pertussis Infection among Children Younger than One-year-old Treated in a University Hospital in Northern Mexico
    Lidia Mendoza-Flores, M.D. ; Laura Paláu-Dávila, M.D. ; Elvira Garza-Gonzalez, PhD ; Adrian Camacho-Ortiz, M.D., PhD ; Jessica Gutiérrez-Ferman, Ph.D. ; Jessica Sauceda-Garza, M.D.
    Posters
  • Bordetellapertussis.pdf (964.0 kB)
  • Mold Allergy in Cystic Fibrosis Patients
    Nikolay Klimko, D.Sc., Professor ; Yana Kozlova, MD, Associate Prof ; Yuliya Borzova, PhD ; Oleg Aak, PhD ; Tatyana Bogomolova, PhD ; Svetlana Ignatieva, PhD ; Ekaterina Burygina, MD
    Clinical Outcomes of Achromobacter Species in Adult Cystic Fibrosis Patients: A Cohort Study
    Brett Edwards, M.D. ; Ranjani Somayaji, M.D. ; Jasper Greysson-Wong, B.Sc. ; Harvey Rabin, M.D. ; Michael Parkins, MD
    Posters
  • Achromobacter IDSA.pdf (1.2 MB)
  • Comparative Nephrotoxicity of Polymyxin B and Colistimethate Sodium in Patients with Cystic Fibrosis
    Ryan L. Crass, PharmD ; W. Cliff Rutter, PharmD ; Donna R. Burgess, RPh ; Craig a. Martin, PharmD, MBA ; David S. Burgess, PharmD, FCCP
    Epidemiology and Clinical Outcomes of Serratia marcescens Infections in Adults with Cystic Fibrosis
    Chris Lata, MD, M.Sc. ; Michael Parkins, MD ; Ranjani Somayaji, M.D. ; Harvey Rabin, M.D. ; Michael Surette, MD ; Ashley Dores, BSc ; Sen Han Phang, MD ; Douglas Storey, PhD
    Elucidating the Dynamic Nature of Bacterial Infections in Cystic Fibrosis (CF) Lower Airways: A Cohort Study
    John Lam, MD ; Ranjani Somayaji, M.D. ; Harvey Rabin, M.D. ; Michael Parkins, MD
    Use of Telavancin for the Treatment of Methicillin-Resistant Staphylococcus aureus-Associated Pulmonary Exacerbations in Patients with Cystic Fibrosis: a Retrospective Case Series
    Katrina Mayr, PharmD ; Louise-Marie Oleksiuk, PharmD ; Keven Robinson, MD ; Michael Myerburg, MD ; Joseph Pilewski, MD
    Posters
  • IDweek2016_Telavancin.pdf (569.3 kB)
  • Correlation of Obesity with Outcomes in Hospitalized Patients with Community-Acquired Pneumonia: Results from the CAPO International Cohort Study
    Paula Peyrani, MD ; Robert Kelley, PhD ; Anupama Raghuram, MD ; Forest Arnold, DO, MSc, FIDSA ; Timothy Wiemken, PhD ; James Chalmers, MD ; Marcos I. Restrepo, MD, MSc ; Jose Bordon, MD, PhD ; Stefano Aliberti, MD ; Julio Ramirez, MD
    Posters
  • Obesity poster.jpg (152.6 kB)
  • Overall Duration of Antibiotic Use among Adults with Community-Acquired Pneumonia Requiring Hospitalization
    Sarah H. Yi, PhD ; Kelly Mccormick, MSPH ; James Baggs, PhD ; Lauri Hicks, DO ; Arjun Srinivasan, MD, FSHEA ; John Jernigan, MD, MS
    Reduction in Acute Respiratory Infection among Military Trainees: Secondary Effects of a Hygiene-based Cluster-Randomized Trial for Skin and Soft Tissue Infection Prevention
    Eugene Millar, PhD ; Carey Schlett, MPH ; Natasha Law, MA ; Wei-Ju Chen, PhD ; Michael D’Onofrio, MD, MPH ; Jason Bennett, MD, MSPH ; Jeffrey Lanier, MD ; David Tribble, MD, DrPH, FIDSA ; Michael Ellis, MD
    Posters
  • 1233_IDWPOSTER.pdf (154.7 kB)
  • Using the Antibiotic Intensity Score to Evaluate Antibiotic Use in Hospitalized Patients with Community-Acquired Pneumonia with Known Versus Unknown Etiology: Results from the CAPO International Cohort Study
    Paula Peyrani, MD ; Forest Arnold, DO, MSc, FIDSA ; Timothy Wiemken, PhD ; Robert Kelley, PhD ; Anupama Raghuram, MD ; Siddartha Bhandary, MD, MPH ; Ahmed Babiker, MBBS ; Jose Bordon, MD, PhD ; Thomas M. File Jr., MD, MSc, MACP, FIDSA, FCCP ; Julio Ramirez, MD
    Posters
  • AIS poster.jpg (163.4 kB)
  • Pneumonia in Adults with Asthma: Impact on Subsequent Asthma Exacerbations
    Rebecca Bornheimer, BA ; Kimberly M. Shea, PhD, MPH ; Reiko Sato, PhD ; Stephen I. Pelton, MD ; Derek Weycker, PhD
    Posters
  • 1235.Bornheimer.pdf (922.6 kB)
  • Sequential Administration of Beta-lactams and Macrolides on the Outcomes of Hospitalized Patients with Community-Acquired Pneumonia: Results from the CAPO International Cohort Study
    Paula Peyrani, MD ; Anupama Raghuram, MD ; Forest Arnold, DO, MSc, FIDSA ; Timothy Wiemken, PhD ; Robert Kelley, PhD ; Mark Metersky, MD ; Julio Ramirez, MD
    Posters
  • Sequential administration.jpg (140.5 kB)
  • Comparison of mortality benefit using standardized treatment in Community Acquired Pneumonia.
    Nikhath Zeeshan, MD ; Marcus J. Zervos, MD, FIDSA ; Yaun Xin, MPH ; Daniela Moreno, MPH ; Anthony D. Harris, MD, MPH, FIDSA, FSHEA ; Steven Lawrance, MD, Msc ; Andrew Masica, MD, MSCI ; Lois Lamaerto, PHD
    Clinical Failure Rates with and without Atypical Coverage in Hospitalized Adults with Community-Acquired Pneumonia: A Meta-analysis
    Khalid Eljaaly, PharmD, CAPPS, BCPS ; Samah Alshehri, PharmD, CAPPS, BCPS ; Ahmed Aljabri, PharmD ; Ivo Abraham, PhD ; David Nix, PharmD
    Posters
  • CAP_Metaanalysis.pdf (513.1 kB)
  • Low Co-Infection Rate in Children with Community-Acquired Pneumonia in Spain
    Enrique Otheo, MD ; Mario Rodríguez, PhD ; Alfredo Tagarro, MD, PhD ; Carmen Vázquez, MD ; Ana Coca, MD ; María Dolores Martín, MD ; Javier González-Sainz, MD, PhD ; Juan Carlos Galán, PhD ; Santiago Moreno, MD, PhD
    Trends of severity and outcomes of patients with pneumococcal pneumonia in relation to seasonality in northern and southern hemipsheres
    Ahmed Babiker, MBBS ; Jose Bordon, MD, PhD ; Jennifer Fuh, DO, MSc ; Siddartha Bhandary, MD, MPH ; Julio Ramirez, MD ; Timothy Wiemken, PhD
    Community Acquired Pneumonia (CAP) in adults hospitalized with ARI during the 2014-2015 Influenza Season: Participant characteristics and viral etiologies
    Ryan E. Malosh, PhD ; Caroline K. Cheng, MS ; Emily T. Martin, MPH, PhD ; Jill M. Ferdinands, PhD, MSc ; Alicia M. Fry, MD, MPH ; Arnold S. Monto, MD, FIDSA
    OVERPRESCRIPTION OF ANTIBIOTICS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN THE ICU
    Rorak Hooten, MD ; Jose Luis Marquez, MD ; Kady Goldlist, MD ; Rafael Urcis, MD ; Matthew Adams, MD ; Kathryn Matthias, PharmD ; David Nix, PharmD ; Mayar Al Mohajer, MD FACP
    A Decade of Invasive Pneumococcal Disease in Ohio Veterans: Challenges in Resistance and Vaccination
    Brigid Wilson, PhD ; Richard Banks, BS ; Robin Jump, MD, PhD ; Federico Perez, MD
    Posters
  • IPD poster FP Oct 19 GIF.gif (610.2 kB)
  • Streptococcus pneumoniae Community-Acquired Pneumonia (SP-CAP) in a French Cohort of Hospitalized Patients : Economic Burden and Impact on Quality of Life (QoL).
    Christian Chidiac, MD, PhD ; Pierre Bonnin, MD ; Bruno Detournay, MD, MBA ; Hajnal-Gabriela Illes, MD ; Jacques Gaillat, MD ; Henri Laurichesse, MD ; Jonathan Messika, MD ; Jean-Damien Ricard, MD ; Grèce Saba, PharmD, Msc ; Patrick Petitpretz, MD ; Gerard De Pouvourville, MD
    The White Blood Cell Count and Prognosis in Pneumococcal Pneumonia
    Julianna G. Gardner, BA ; Divya R. Bhamidipati, BS ; Adriana M. Rueda, MD ; Edward Graviss, PhD, MPH ; Duc Nguyen, PhD ; Daniel M. Musher, MD
    Predictive Factors of Treatment Failure of Methicillin-resistant Staphylococcus aureus Pneumonia: A Multicenter Prospective Observational Study
    Taiga Miyazaki, MD ; Koichi Izumikawa, MD ; Hiroshi Kakeya, MD ; Hiroshi Mukae, MD ; Yuichiro Shindo, MD ; Yoshihiro Yamamoto, MD ; Katsunori Yanagihara, MD ; Kazuhiro Tateda, MD ; Kazunori Tomono, MD ; Tadashi Ishida, MD ; Yoshinori Hasegawa, MD ; Masaharu Nishimura, MD ; Yoshihito Niki, MD ; Akira Watanabe, MD ; Kazui Soma, MD ; Shigeru Kohno, MD
    Hyponatremia is an inflammatory marker in children with community-acquired pneumonia
    Enrique Otheo, MD ; Mario Rodríguez, PhD ; Sinziana Stanescu, MD ; Ana Coca, MD ; María Dolores Martín, MD ; Javier González-Sainz, MD, PhD ; Juan Carlos Galán, PhD ; Alfredo Tagarro, MD, PhD
    Disease burden and risk factors of hospitalized community-acquired pneumonia in Korean adults
    Min Joo Choi, MD ; Joon Young Song, MD ; Ji Yun Noh, MD ; Jin Gu Yoon, M.D. ; Hak Jun Hyun, MD ; Jae Won Yun, MD ; Woo Joo Kim, MD ; Hee Jin Cheong, MD
    Polymyxin B- Compared to Beta-Lactam- Based Regimens for the Treatment of Carbapenem Resistant Gram Negative Bacterial Pneumonia
    Rosy Priya Kodiyanplakkal, M.D. ; Catherine Devoe, MD ; Lucy Y. Cheng, MD ; Joshua W. Bliss, PharmD ; Magdalena Sobieszczyk, MD, MPH ; Christine J. Kubin, PharmD BCPS (AQ-ID)
    Empiric Double Coverage for Healthcare-Associated Pneumonia (HCAP) – Is it Still Necessary?
    Abhishek Deshpande, MD, PhD ; Sarah Haessler, MD ; Kyle Brizendine, MD ; Peter Lindenauer, MD, MSc ; Tara Lagu, MD, MPH ; Pei-Chun Yu, MS ; Paul Bakaki, MD, PhD ; Penelope Pekow, PhD ; Michael Rothberg, MD, MPH
    Impact of inappropriate empiric treatment of Enterobacteriaceae UTI, pneumonia and sepsis on hospital outcomes
    Marya D. Zilberberg, MD, MPH ; Brian Nathanson, PhD ; Kate Sulham, MPH ; Weihong Fan, MS ; Andrew F. Shorr, MD, MPH
    Posters
  • Medicine_poster_IET (2).pdf (98.8 kB)
  • Community-Acquired Pneumonia (CAP) Therapy is Insufficient for most Patients with Culture-positive Healthcare-Associated Pneumonia (HCAP)
    Abhishek Deshpande, MD, PhD ; Sarah Haessler, MD ; Kyle Brizendine, MD ; Peter Lindenauer, MD, MSc ; Tara Lagu, MD, MPH ; Pei-Chun Yu, MS ; Paul Bakaki, MD, PhD ; Marya D. Zilberberg, MD, MPH ; Thomas Higgins, MD, MBA ; Michael Rothberg, MD, MPH
    Acute Onset of Pneumococcal Pneumonia Following Hospitalization and Surgery
    Julianna G. Gardner, BA ; Rahul S. Kamath, B.S. ; Adriana M. Rueda, MD ; Daniel M. Musher, MD
    Epidemiology of Healthcare-Associated Pneumonia (HCAP) as Assessed by Blood Cultures versus Respiratory Cultures
    Abhishek Deshpande, MD, PhD ; Sarah Haessler, MD ; Kyle Brizendine, MD ; Peter Lindenauer, MD, MSc ; Pei-Chun Yu, MS ; Marya D. Zilberberg, MD, MPH ; Paul Bakaki, MD, PhD ; Thomas Higgins, MD, MBA ; Michael Rothberg, MD, MPH
    Staphylococcus aureus colonized patients receiving mechanical ventilation progress to pneumonia despite antibiotic treatment
    Ekaterina Kabak, MD ; Zoltan Magyarics, MD, PhD ; Ahsan Waqas, MD ; Jana Hudcova, MD ; Jawad Rashid, MD ; Caitlin Scopa, MSC ; Maryam Khan, MD ; Marie Goggin, MT(ASCP)(SM) ; Lukas Stulik, MSC ; Eszter Nagy, MD, PhD
    Pneumococcal Colonization Among Tracheostomy Tube Dependent Children in Columbus, Ohio
    Guliz Erdem, MD ; Anirudh Singh, PhD ; Anthony Brusnahan, n/a ; Amber Moore, n/a ; William Barson, MD ; Amy Leber, PhD ; Serkan Atici, MD ; Samantha King, PhD
    Early Administration of Colistin Might Improve The Outcome of Carbapenem Resistant Acinetobacter baumannii Bacteremic Pneumonia 
    Eun Jung Lee, MD ; Seong Yeon Park, MD ; Tark Kim, MD ; Shi Nae Yu, MD ; Ki-Ho Park, MD ; Mi Suk Lee, MD, PhD ; Min Hyok Jeon, MD ; Eun Ju Choo, MD ; Tae Hyong Kim, MD, PhD
    Posters
  • 2016_IDSA_LEJ.pdf (162.8 kB)
  • Clinical Use of Ceftaroline Fosamil for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
    Keith Kaye, MD ; Ananthakrishnan Ramani, MD ; George Udeani, PharmD, DSc, FCP, FCCP ; Timothy Pasquale, PharmD ; H. David Friedland, MD
    Nonbronchoscopic-BAL for Suspected Ventilator-Associated Pneumonia: Factors that Drive Unnecessary Antimicrobial Prescribing
    Kaitlyn Moorehead, PharmD ; Elizabeth Zhu, PharmD, BCPS ; Monica Donnelley, PharmD, BCPS ; Machelle D. Wilson, PhD ; Jennifer Brown, MD
    Posters
  • IDSA poster 2016.pdf (441.5 kB)
  • Are Previously Identified Risk Factors Truly Predictive of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Pneumonia?
    Hilary Gerwin, PharmD ; Siyun Liao, Pharm.D., PhD, BCPS ; Maria Guido, Pharm.D., BCPS ; Brittany Woolf, PharmD, BCPS ; Madhuri Sopirala, MD, MPH
    Efficacy, nephrotoxicity, and incidence of Clostridium difficile infection with broad spectrum antibiotic regimens in elderly patients with nosocomial pneumonia
    Kaitlyn B. Kalata, PharmD ; Sue Kim, PharmD, BCPS ; Ursula C. Patel, PharmD, BCPS AQ-ID ; Raymond Byrne, PharmD, BCPS ; Katie J. Suda, PharmD, M.S.
    Posters
  • 1266_IDWPOSTER.pdf (881.0 kB)
  • Who Gets Treated for Influenza: Predictors of Antiviral Prescription Receipt Among Children with Outpatient Influenza-Like Illness
    Kristen Feemster, MD, MPH, MSHP ; Susan Coffin, MD, MPH, FSHEA, FPIDS ; Natasha Sastri, BS, MPH (c)
    Influenza antiviral prescribing practices among outpatients with acute respiratory illnesses during influenza season—United States, 2010-11 to 2013-14
    Courtney Strickland, BS ; Alicia M. Fry, MD, MPH ; Jerome Tokars, MD, MPH ; Jufu Chen, PhD ; Fiona Havers, MD, MHS
    Posters
  • FINAL_POSTER_CES_20OCT16.pdf (476.6 kB)
  • Evaluation of the Utility of CMS Claim Data for Early Detection of Increasing Influenza Activity
    Lin Fan, PhD ; Rex Astles, PhD ; Howard Burkom, PhD ; Zheyu Hu, Ph.D, M.D
    Differences in self-reported severity of symptoms between women and men experiencing influenza-like illness
    Robert Deiss, MD ; Wei-Ju Chen, PhD ; Christian Coles, PhD ; Mary Fairchok, MD ; Christina Schofield, MD FACP, FIDSA ; Patrick Danaher, MD, FIDSA ; Erin Hansen, BS ; Tahaniyat Lalani, MD ; Jacqueline Owens Milzman, M.S. ; Deepika Mor, MS ; Michelande Ridore, MS ; Timothy Burgess, MD ; Eugene Millar, PhD ; John Arnold, MD
    Posters
  • ARI ID Week 2016 poster.pdf (526.2 kB)
  • Antibiotic Prescription Patterns Related to Influenza-like Infection
    Mary Fairchok, MD ; Wei-Ju Chen, PhD ; Christina Schofield, MD FACP, FIDSA ; Tahaniyat Lalani, MD ; Patrick Danaher, MD, FIDSA ; John Arnold, MD ; Michael Rajnik, MD ; Leslie Malone, MS, MB(ASCP)CM ; Elena Grigorenko, PhD ; Donald Stalons, PhD, D(ABMM), MPH ; Timothy Burgess, MD ; Eugene Millar, PhD ; Christian Coles, PhD
    Posters
  • 1273_IDWPOSTER.pdf (47.4 kB)
  • Use of Rapid Influenza Diagnostic Tests: Impact on Treatment of Hospitalized Influenza Cases, New York – 2012-2015
    Eva Pradhan, MPH, MHA ; Suzanne Mcguire, MPH ; Nancy L. Spina, MPH ; Priscela Perez, MPH ; Jemma Rowlands, MPH ; Gregory Farrell, BA ; Kristen St. George, PhD ; Shelley M. Zansky, PhD
    Posters
  • Flu poster IDWEEK2016.pdf (435.0 kB)
  • Epidemiological Description of the Influenza Virus Infection Period During the First Four Months of 2016 in a Teaching Third Level Hospital in Mexico City
    Margarita Virgen-Cuevas, MD ; Jose Juan Donis-Hernandez, DR ; Claudia Lopez Enriquez, DR ; Lucia Martinez-Hernandez, MD ; Juan Millan Camacho, MD ; Armando Armenta Alvarez, MD
    Posters
  • Influenza EUA Modificado.pdf (357.6 kB)
  • Burden of respiratory syncytial virus disease among adults in the united states from 1997 to 2012
    Susan Pastula, MPH ; Judith Hackett, BSc PHM MBA MPH ; Jenna E. Coalson, PhD, MPH ; Xiaohui Jiang, MS ; Tonya Villafana, PhD MPH ; Jon P. Fryzek, PhD, MPH ; Christopher S. Ambrose, MD, MBA
    Posters
  • ID Week Poster.pdf (231.2 kB)
  • A Comparison of RSV Viral Loads Between Nasopharyngeal and Mid-Turbinate Swabs from Children <24 Months with RSV Infection
    Anne J. Blaschke, MD, PhD, FIDSA, FPIDS ; Matthew Mckevitt, PhD ; Krow Ampofo, MD, FIDSA, FPIDS ; Tammi Lewis, BS ; Ying Guo, PhD ; Julianna Dorsch, BS ; Erin Vanderhoof, BS ; Pricilla Rosen, BSc ; Volker Freimann, BS ; E. Kent Korgenski, MS ; Seth Toback, M.D. ; Jason Chien, M.D.
    Posters
  • Blaschke IDWeek 2016.pdf (107.7 kB)
  • SENTINEL1: An Ongoing Multicenter Observational Study of Respiratory Syncytial Virus Hospitalizations Among US Infants Born at 29–35 Weeks’ Gestational Age Not Receiving Immunoprophylaxis in 2014–2016
    Evan J. Anderson, MD ; John P. Devincenzo, MD ; Paul A. Checchia, MD ; Michael L. Forbes, MD ; Natasha Halasa, MD, MPH, FPIDS ; Leonard R. Krilov, MD ; Pia S. Pannaraj, MD, MPH ; Eric A. Simões, MB, BS, DCH, MD ; Joseph B. Domachowske II, MD, FIDSA, FPIDS ; Claudia M. Espinosa, MD, MSc ; Robert C. Welliver Sr., MD ; Leslie I. Wolkoff, MD ; Scott J. McBride, MA ; Kimmie K. McLaurin, MS ; Veena R. Kumar, MD, MPH ; Christopher S. Ambrose, MD, MBA
    Oxygen-free days and mortality among hematopoietic cell transplant recipients with respiratory syncytial virus (RSV) infection
    Alpana Waghmare, MD ; Hu Xie, MS ; Louise Kimball, RN, PhD ; Jessica Yi, BS ; Sezan Ozkok, MD ; Wendy Leisenring, ScD ; Janet Englund, MD, FIDSA ; Timothy Watkins, MD ; Jason Chien, M.D. ; Michael Boeckh, MD, FIDSA
    Posters
  • IDweek 2016 FINAL.pdf (270.4 kB)
  • Impact of RSV Testing on Antibiotic Use in Adults Presenting for Emergency Care
    Marci Drees, MD, MS ; Tom Laughery, BS ; Sarojini Misra, MS, SM (ASCP), SM (AAM) ; Ryan C. Arnold, MD
    Posters
  • RSV_IDweek_2016_FINAL.pdf (755.0 kB)
  • Reduced numbers of T–cell, B-cell and CD4+ follicular helper T cell (Tfh) populations in infants with acute RSV infection
    Santiago Panesso, MD ; Victoria Best, PhD ; Raquel Giacomelli Cao, MD PhD ; Fang Ye, PhD ; Santtu Heinonen, MD, PhD ; Octavio Ramilo, MD, FPIDS ; Asuncion Mejias, MD, PhD
    Respiratory Syncytial Virus Infections in a Pediatric Intensive Care Unit in Japan
    Yoshiaki Cho, MD ; Takemi Murai, MD, PhD ; Yukitsugu Nakamura, MD, PhD ; Takayuki Yamanaka, MD ; Kahoru Fukuoka, MD ; Hiroki Sakurai, MD ; Yuta Aizawa, MD, PhD ; Mihoko Isogai, MD ; Yuho Horikoshi, MD ; Kazue Kinoshita, MS
    Posters
  • IDweek poster最終版.pdf (816.5 kB)
  • Caregiver Impact of Respiratory Syncytial Virus Hospitalizations among US Preterm Infants 29–35 Weeks’ Gestational Age
    Robin M. Pokrzywinski, MHA ; Laura L. Swett, PhD ; Jumi Yi, MD ; Veena R. Kumar, MD, MPH ; Kimmie K. McLaurin, MS ; Nancy K. Leidy, PhD
    Correlation of Corrective Eyewear to Acute Respiratory Infection (ARI) among Outpatient Healthcare Personnel (HCP)
    Amanda Krosche, BS ; Mary Bessesen, MD ; Derek Cummings, PhD ; Charlotte Gaydos, DrPH, FIDSA ; Cynthia Gibert, MD, MSc, FIDSA ; Geoffrey Gorse, MD, FIDSA ; Jenna Los, MLA ; Ann-Christine Nyquist, MD, MSPH, FPIDS ; Connie Price, MD ; Lewis Radonovich, MD ; Nicholas Reich, PhD ; Maria C. Rodriguez-Barradas, MD, FIDSA ; Michael S. Simberkoff, MD, FIDSA ; Trish M. Perl, MD, MSc, FIDSA, FSHEA
    Healthcare Worker (HCW) Perceptions of Healthcare-associated Respiratory Infection in Pediatric Clinics: A Qualitative Study
    Folasade Odeniyi, MPH ; Julia E. Szymczak, PhD ; Susan Coffin, MD, MPH, FSHEA, FPIDS ; Joshua Metlay, MD, PhD ; Kristen Feemster, MD, MPH, MSHP
    Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples from Hematopoietic Cell Transplantation Recipients and Hematologic Malignancy Patients
    Chikara Ogimi, MD ; Alpana Waghmare, MD ; Jane Kuypers, PhD ; Hu Xie, MS ; Wendy Leisenring, ScD ; Cecilia Yeung, MD ; Sachiko Seo, MD ; Su-Mi Choi, M.D., Ph.D ; Keith Jerome, MD, PhD ; Janet Englund, MD, FIDSA ; Michael Boeckh, MD, FIDSA
    Posters
  • IDWeek_2016_poster_HCoV5.pdf (552.8 kB)
  • Viruses Associated with Acute Respiratory Illnesses (ARI) in Hospitalized Pediatric Patients 5-17 Years of Age in the US
    Leila C. Sahni, MPH ; Pedro Piedra, MD ; Flor Munoz, MD ; Julie Boom, MD ; Parvin H. Azimi, MD ; Rangaraj Selvarangan, PhD ; Natasha Halasa, MD, MPH, FPIDS ; Janet Englund, MD, FIDSA ; Geoffrey Weinberg, MD, FIDSA, FPIDS ; Daniel Payne, PhD, MSPH ; Daniella Figueroa-Downing, MPH ; Alicia M. Fry, MD, MPH ; Angela P. Campbell, MD, MPH, FPIDS ; Susan Gerber, MD ; Brian Rha, MD, MSPH
    Posters
  • Sahni IDWeek 1292.pdf (119.9 kB)
  • Factors Associated with Antibiotic Exposure in Children less than 3 Years Old Hospitalized with Bronchiolitis
    Katherine Backman, MD ; Chelsea Caya, MScPH ; Gaston De Serres, MD ; Julie Carbonneau, MSc ; Marie-Eve Hamelin, PhD ; Guy Boivin, MD, MSc ; Jesse Papenburg, MD, MSc
    The Effect of Regular Physical Exercise on Catching Upper Respiratory Tract Infections
    Alpay Azap, professor ; Ceren Yüceer, Medical Student ; Onur Nurlu, Medical Student ; Rukiye Aysu Revanlı, Medical Student ; Sarpcan Maden, Medical Student ; Anıl Tarık Saygılı, Medical student ; Can Ateş, PhD
    Posters
  • presentation no 1294.pdf (683.5 kB)
  • Neutrophil activation in infants hospitalized with severe respiratory viral infection
    Hassan El Chebib, M.D. ; Cynthia Bonville, MS ; Joseph B. Domachowske II, MD, FIDSA, FPIDS ; Manika Suryadevara, MD
    Posters
  • ID week Updated Sep 07.pdf (128.6 kB)
  • An Observational Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico
    Juan-Francisco Galán-Herrera, MD, MS ; Arturo Galindo-Fraga, MD, MS ; Daniel Noyola, MD ; Martin Magaña-Aquino, MD ; Sarbelio Moreno-Espinosa, MD, MS ; Beatriz Llamosas-Gallardo, MD ; Alejandra Ramírez-Venegas, MD ; Laura Freimanis, MD, PhD ; Sally Hunsberger, MD ; M. Lourdes Guerrero Almeida, MD, MS ; Mary Smolskis, R.N, M.A. ; John Beigel, MD ; Guillermo Ruiz-Palacios, MD, FIDSA
    Posters
  • IDWeek2016_LaRed_ILI2014.png (521.0 kB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.